Purification, Characterization and Comparison Between Two New L-asparaginases from PG03 and PG04
Overview
Authors
Affiliations
Background: L-asparaginase has been used as a chemotherapeutic agent in treatment of lymphoblastic leukemia. In the present investigation, sp. PG03 and sp. PG04 were studied.
Methods: L- asparaginases were produced using different culture media and were purified using ion exchange chromatography.
Results: Maximum productivity was obtained when asparagine was used as the nitrogen source at pH 7 and 48 h after cultivation. New intracellular L-asparaginases showed an apparent molecular weight of 25 kDa and 30 kDa by SDS-PAGE respectively. These enzymes were active in a wide pH range (3-9) with maximum activity at pH 6 for PG03 and pH 7 for PG04 L-asparaginase. PG03 enzyme was optimally active at 37 ˚C and PG04 maximum activity was observed at 40˚C. Kinetic parameters and of both enzymes were studied using L-asparagine as the substrate. Thermal inactivation studies of PG03 and PG04 L-asparaginase exhibited t of 69.3 min and 34.6 min in 37 ˚C respectively. Also T and ∆G of inactivation were measured for both enzymes.
Conclusion: The results revealed that both enzymes had appropriate characteristics and thus could be a potential candidate for medical applications.
Kumar V, Anand P, Srivastava A, Akhter Y, Verma D 3 Biotech. 2024; 14(10):230.
PMID: 39280800 PMC: 11391003. DOI: 10.1007/s13205-024-04072-w.
Abdelrazek N, Saleh S, Raafat M, Ali A, Aboulwafa M AMB Express. 2024; 14(1):51.
PMID: 38704453 PMC: 11069494. DOI: 10.1186/s13568-024-01700-9.
Sundaram S, Kannan A, Chintaluri P, Ganapathy Vilasam Sreekala A, Nathan V Int Microbiol. 2024; 27(6):1765-1779.
PMID: 38519776 DOI: 10.1007/s10123-024-00493-y.
Characterization of a Type II L-Asparaginase from the Halotolerant CH11.
Arredondo-Nunez A, Monteiro G, Flores-Fernandez C, Antenucci L, Permi P, Zavaleta A Life (Basel). 2023; 13(11).
PMID: 38004285 PMC: 10672034. DOI: 10.3390/life13112145.
Alrumman S, Mostafa Y, Al-Izran K, Alfaifi M, Taha T, Elbehairi S Sci Rep. 2019; 9(1):3756.
PMID: 30842557 PMC: 6403232. DOI: 10.1038/s41598-019-40512-x.